Qalabka caafimaadka ee Lepu COVID-19 antigen xirmada baarista degdega ah AMRDT106

Faahfaahin Deg Deg ah

Tusaalaha diyaarinta waxay qaadan kartaa iyadoo loo eegayo tillaabooyinka qalliinka.
1.Specimen reagent saarista
2. Ku dhaaf suufka tuubada reagent hal daqiiqo.
3.Ku dheji tuubada soo saarista faraha.
4. Geli sanka.

Baakadaha & Bixinta

Tilmaamaha

Qalabka caafimaadka ee Lepu COVID-19 antigen xirmada baarista degdega ah AMRDT106

Muunadaha lagu ogaanayo waxaa ka mid ah suufka sanka iyo suufka oropharyngeal.

Qalabka caafimaadka ee Lepu COVID-19 antigen xirmada tijaabada degdega ah ee AMRDT106 Tilmaamaha
Kaassette Tijaabada Degdegga ah ee Antigen-ka ee COVID-19 AMRDT106:
Ogaanshaha borotiinka ee SARS-CoV-2 Nucleocapsid:

Nucleocapsid (N) borotiinka waa borotiinka ugu badan ee si aad ah loogu ilaaliyo SARS-CoV-2.
borotiinka N waxa loo istcimaalaa sidii sheyga xudunta u ah baadhista degdega ah ee reagent forimmunology ee suuqa.

Kaasset-ka Tijaabada Degdegga ah ee Antigen-ka ee ay soo saartay Clongene ee COVID-19:
Clongene waxay soo saartay kasette-ka COVID-19 Antigen Rapid Test Cassette.
(CGIA) si loo ogaado borotiinka nucleocapsid ee SARS-CoV-2 waxay ku saleysan tahay mabda'a farsamada-sandwich-ka-la-laaban.

Qalabka caafimaadka Lepu ee COVID-19 antigen xirmada baarista degdega ah ee AMRDT106 AMRDT106 KULA ISTICMAALO:

Cassette-ka Antigen Degdegga ah ee tijaabada ah ee COVID-19 waa immunoassay socodka lateral ee loogu talagalay ogaanshaha tayada leh ee SARS-CoV-2 nucleocapsid antigens ee sanka sanka iyo suufka oropharyngeal ee shakhsiyaadka looga shakisan yahay CoVID-19 bixiyaha daryeelkooda. Natiijooyinka ayaa loogu talagalay aqoonsiga of SARS-CoV-2 nucleocapsid antigen.Antigen guud ahaan waxaa lagu ogaan karaa suufka nasopharyngeal iyo oropharyngeal swab inta lagu jiro marxaladda ba'an ee caabuqa.

Natiijooyinka wanaagsani waxay muujinayaan joogitaanka antigens fayras, laakiin xidhiidhka kiliinikada ee taariikhda bukaanka iyo macluumaadka kale ee ogaanshaha waa lagama maarmaan si loo go'aamiyo heerka caabuqa. Natiijooyinka wanaagsan kama saarayaan caabuqa bakteeriyada ama la-qaadista fayraska kale. Natiijooyinka xun kama saarayaan infekshanka SARS-CoV-2 waana inaan loo isticmaalin saldhigga keliya ee daaweynta ama go'aamada maareynta bukaanka, oo ay ku jiraan go'aamada xakameynta caabuqa.

Natiijooyinka taban waa in lagu tixgaliyaa macnaha guud ee bukaan-socodka ee dhawaan soo shaac baxay, taariikhda iyo joogitaanka calaamadaha bukaan-socodka iyo astaamaha la socda COVID-19, oo lagu xaqiijiyo baaritaanka molecular, haddii loo baahdo maaraynta bukaan-socodka. waxaa loogu talagalay in loo isticmaalo shaqaale shaybaar caafimaad oo tababaran oo si gaar ah loo baray loona tababaray hababka ogaanshaha vitro.

Qalabka caafimaadka ee Lepu COVID-19 antigen xirmada baarista degdega ah ee AMRDT106 Noocyada:
Muunadaha lagu ogaanayo waxaa ka mid ah suufka sanka iyo suufka oropharyngeal.
Tusaalaha diyaarinta waxay qaadan kartaa iyadoo loo eegayo tillaabooyinka qalliinka.
1.Specimen reagent saarista
2. Ku dhaaf suufka tuubada reagent hal daqiiqo.
3.Ku dheji tuubada soo saarista faraha.
4. Geli sanka.

Qalabka caafimaadka ee Lepu COVID-19 antigen xirmada baarista degdega ah ee AMRDT106 COMPOSITION:
Cajalka tijaabada waxa ku jira xariijimo xuubka ka samaysan oo lagu dahaadhay anti-SARS-CoV-2 nuclenocapsid borotiinka monoclonal antibody ee khadka tijaabada T, iyo suuf dheeha ah oo ka kooban dahab kolloid ah oo ay weheliso SARS-CoV-2 nuclenocapsid borotiinka monoclonal antibody.